Skip to main content

and
  1. Article

    Open Access

    Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

    Giovanni Caocci, Olga Mulas, Isabella Capodanno in Blood Cancer Journal (2020)